Amber ListRecovering

IBRXImmunityBio, Inc.

Healthcare · Biotechnology · mid-cap ($7.3B)
-36.9%
from rolling 252-day high of $12.43 set 2026-02-25 · 176d ago
Current
$7.84
Decline depth
-36.9%
Decline σ
1.8σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$IBRX landed on the list 2026-03-25, down 35.1% from its 52-week high that day — now down -36.9%.

That's 2.2 percentage points deeper than the day it joined. It bottomed 46.4% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-25 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

IBRX qualifies for the Amber List on decline depth.

Decline depth
-36.9%
From rolling 252-day high of $12.43, 176d ago. Past the 30% Amber threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
1.8σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (3.58% per day).

The structural read

What price action says about IBRX.

IBRX qualifies for the Amber List on decline depth — down -36.9% from its rolling 252-day high.

Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.

Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether IBRX's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.

Upstream TFC read: moderate alignment, current phase weekly. Last bar types — daily 2D (red), weekly 2U (green), monthly 1 (green).

Earnings on file: 2026-05-07. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about IBRX

What people ask.

Why is IBRX on Broken Stocks?

IBRX qualifies for the Amber List on decline depth. It is down -36.9% from its rolling 252-day high of $12.43, set on 2026-02-25 — 176d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for IBRX?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — IBRX is still Amber List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is IBRX a falling knife?

Not by the strict technical definition. IBRX is down -36.9% from its 52-week high, but that high was set 176d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. IBRX is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is IBRX a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is IBRX trading inside its 52-week range?

At $7.84, IBRX sits 56.2% of the way from its 52-week low ($1.95) to its 52-week high ($12.43). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has IBRX been declining?

The current 36.9% decline accrued over 176d, which annualizes to roughly -76.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does IBRX compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 34 Amber, 39 Watch, with 49 showing recovering structural signals. Median sector decline is -36.1% — IBRX's decline is deeper than the sector median.

Does IBRX's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.